Loading...

OTC Markets

Totals

Securities

12,258

Dollar Vol

$3.4B

Share Vol

4.2B

Trades

418,879

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

Market Activity
Stock
BEAM
Financials

BEAM
Beam Therapeutics Inc.

Common Stock

24.41

0.09

0.37%

Delayed (15 Min) Trade Data: 12:00am 09/22/2025

Financials

Fiscal year ends 12/31

| Values in 000s USD

Income Statement

Balance Sheet

Cash Flow

Annual

Semi-Annual

Quarterly

Income Statement

Balance Sheet

Cash Flow

Annual

Semi-Annual

Quarterly

2024

12/30/2024

2023

12/30/2023

2022

12/30/2022

2021

12/30/2021

12/30/2024

2024-12-31 00:00:00

12/30/2023

2024-12-31 00:00:00

12/30/2022

2024-12-31 00:00:00

12/30/2021

2024-12-31 00:00:00

Revenues

Total Revenue

63,518

377,709

63,518

60,920

63,518

51,844

63,518

Cost of Revenue

Gross Profit

63,518

377,709

63,518

60,920

63,518

51,844

63,518

Operating Expenses

Research and Development

367,561

437,381

367,561

311,594

367,561

387,087

367,561

Sales, General and Admin

111,525

116,813

111,525

87,805

111,525

57,222

111,525

Non-Recurring Items

Other

Total Expenses

479,086

554,194

479,086

399,399

479,086

444,309

479,086

Operating Income

(415,568)

(176,485)

(415,568)

(338,479)

(415,568)

(392,465)

(415,568)

Income from Continuing Operations

Additional Income / Expense Items

(10,229)

(1,352)

(10,229)

63,004

(10,229)

21,836

(10,229)

Earnings Before Interest and Taxes

(415,568)

(176,485)

(415,568)

(338,479)

(415,568)

(392,465)

(415,568)

Interest Expense

Earnings Before Tax

(376,703)

(131,161)

(376,703)

(260,178)

(376,703)

(370,638)

(376,703)

Income Tax

1,366

3,410

Minority Interest

(25,500)

Equity Earnings

(25,500)

Net Income Cont. Operations

(376,742)

(132,527)

(376,742)

(289,088)

(376,742)

(370,638)

(376,742)

Non-Recurring Events

Discontinued Operations

Extraordinary Operations

Effect of Accounting Changes

Net Income

(376,742)

(132,527)

(376,742)

(289,088)

(376,742)

(370,638)

(376,742)

Key Financial Ratios

Earnings Per Share

-4.58

-1.72

-4.58

-4.13

-4.58

-5.77

-4.58

Price/Earnings

-5.4148

Gross Margin

Operating Margin

-6.5425

-0.4672

-6.5425

-5.5561

-6.5425

-7.5701

-6.5425

Financial data presented is provided by Edgar Online and may differ from information contained in the issuer's annual and periodic reports, which are available under the "Disclosure" tab.

Neither the issuer nor OTC Markets Group is liable for any errors, omissions or other defects in the data presented below, or for any decisions taken in reliance of the data.

For information not originally reported in U.S. Dollars, conversion is based on applicable exchange rate on the last day of the period reported.

© 2025 EDGAR®Online LLC, a subsidiary of OTC Markets Group. All rights reserved. EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Market Groups Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.

Nasdaq

Daily Advancers